SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-056986
Filing Date
2018-11-02
Accepted
2018-11-02 18:00:31
Documents
1
Period of Report
2018-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8171
  Complete submission text file 0001209191-18-056986.txt   9805
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 6701 KAISER DRIVE FREMONT CA 94555
Business Address
BEHRENS M KATHLEEN (Reporting) CIK: 0001211701 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14895 | Film No.: 181158276